Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experience.

Saved in:
Bibliographic Details
Title: Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experience.
Authors: Katragadda L; Department of Medicine, University of Florida, Gainesville, FL, USA., McCullough LM; Department of Medicine, University of Florida, Gainesville, FL, USA., Dai Y; Department of Biostatistics, University of Florida, Gainesville, FL, USA., Hsu J; Department of Medicine, University of Florida, Gainesville, FL, USA., Byrne M; Department of Medicine, University of Vanderbilt, Nashville, TN, USA., Hiemenz J; Department of Medicine, University of Florida, Gainesville, FL, USA., May S; Department of Medicine, University of Florida, Gainesville, FL, USA., Cogle CR; Department of Medicine, University of Florida, Gainesville, FL, USA., Norkin M; Department of Medicine, University of Florida, Gainesville, FL, USA., Brown RA; Department of Medicine, University of Florida, Gainesville, FL, USA., Wingard JR; Department of Medicine, University of Florida, Gainesville, FL, USA., Chang M; Department of Biostatistics, University of Florida, Gainesville, FL, USA., Moreb JS; Department of Medicine, University of Florida, Gainesville, FL, USA.
Source: Clinical transplantation [Clin Transplant] 2016 Aug; Vol. 30 (8), pp. 894-900. Date of Electronic Publication: 2016 Jun 29.
Publication Type: Journal Article
Journal Info: Publisher: Munksgaard Country of Publication: Denmark NLM ID: 8710240 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1399-0012 (Electronic) Linking ISSN: 09020063 NLM ISO Abbreviation: Clin Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first